Daryl L. Davies, PhD, was awarded a 5-year R01 grant renewal in the amount of $1,250,000 from the National Institute on Alcohol Abuse and Alcoholism for his project entitled “Regulation of Alcohol Intake by Purinergic P2X4 Receptors” on September 7.
“Alcohol use disorder (AUD) has a staggering socio-economic impact, yet current therapeutic strategies are largely inadequate to treat these disorders,” Davies said.
The Davies laboratory has identified P2X4 receptors (P2X4Rs) as a target for the development of drugs to treat AUD. Findings from the current funded grant will provide strong support for this hypothesis from several directions including development of lead compounds for treatment and or prevention of AUD.
You can read more about Dr. Davies’ work on the USC School of Pharmacy website.
We congratulate Dr. Davies and his research team!